184 related articles for article (PubMed ID: 33104795)
1. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.
Bosch FTM; Mulder FI; Kamphuisen PW; Middeldorp S; Bossuyt PM; Büller HR; van Es N
Blood Adv; 2020 Oct; 4(20):5215-5225. PubMed ID: 33104795
[TBL] [Abstract][Full Text] [Related]
2. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.
van Es N; Ventresca M; Di Nisio M; Zhou Q; Noble S; Crowther M; Briel M; Garcia D; Lyman GH; Macbeth F; Griffiths G; Iorio A; Mbuagbaw L; Neumann I; Brozek J; Guyatt G; Streiff MB; Baldeh T; Florez ID; Gurunlu Alma O; Agnelli G; Ageno W; Marcucci M; Bozas G; Zulian G; Maraveyas A; Lebeau B; Lecumberri R; Sideras K; Loprinzi C; McBane R; Pelzer U; Riess H; Solh Z; Perry J; Kahale LA; Bossuyt PM; Klerk C; Büller HR; Akl EA; Schünemann HJ;
J Thromb Haemost; 2020 Aug; 18(8):1940-1951. PubMed ID: 32336010
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis.
Zhou H; Ye LL; Zhou JT; Ma FX; Ma JJ; Zhang JH
Surg Endosc; 2024 Mar; 38(3):1131-1138. PubMed ID: 38267639
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis.
Zhou H; Chen TT; Ye LL; Ma JJ; Zhang JH
World J Surg Oncol; 2024 Feb; 22(1):69. PubMed ID: 38403630
[TBL] [Abstract][Full Text] [Related]
5. Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis.
Hafiz A; Alkofide H; Al Sulaiman K; Joharji H; Aljohani S; Sarkhi KA; Alharbi R; Korayem GB; AlFaifi M; Alsohimi S; Aljuhani O
Clin Appl Thromb Hemost; 2023; 29():10760296231191123. PubMed ID: 37547931
[TBL] [Abstract][Full Text] [Related]
6. Effect of extended duration of thromboprophylaxis for medically ill patients.
Wang X; Chen Y; Wen D; You C; Ma L
Eur J Intern Med; 2023 Jul; 113():22-30. PubMed ID: 37029050
[TBL] [Abstract][Full Text] [Related]
7. The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines.
Alsubaie NS; Al Rammah SM; Alshouimi RA; Alzahrani MY; Al Yami MS; Almutairi AR; Alfayez OM; Korayem GB; Almohammed OA
Thromb J; 2021 Oct; 19(1):76. PubMed ID: 34717653
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
Sanfilippo KM; Carson KR; Wang TF; Luo S; Edwin N; Kuderer N; Keller JM; Gage BF
Res Pract Thromb Haemost; 2022 Jan; 6(1):e12634. PubMed ID: 35028491
[TBL] [Abstract][Full Text] [Related]
9. Comparison of risk prediction scores for cancer-associated thrombosis in ambulatory cancer patients not receiving thromboprophylaxis: A prospective cohort study in a South-East Asian population.
Thipbumrung S; Niprapan P; Suprasert P; Ketpueak T; Tantiworawit A; Punnachet T; Hantrakun N; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C
Thromb Res; 2023 Dec; 232():138-144. PubMed ID: 37979462
[TBL] [Abstract][Full Text] [Related]
10. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 thromboprophylaxis. New evidence.
Ferrandis R; Sierra P; Gomez-Luque A
Rev Esp Anestesiol Reanim (Engl Ed); 2024 Jan; 71(1):34-47. PubMed ID: 37678450
[TBL] [Abstract][Full Text] [Related]
12. Extended-duration thromboprophylaxis following major abdominopelvic surgery - For everyone or selected cases only?
Noureldin A; Ivankovic V; Delisle M; Wang TF; Auer RC; Carrier M
Thromb Res; 2024 Mar; 235():175-180. PubMed ID: 38354471
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis.
Liu M; Wang G; Li Y; Wang H; Liu H; Guo N; Han C; Peng Y; Yang M; Liu Y; Ma X; Yu K; Wang C
Ther Adv Med Oncol; 2020; 12():1758835920907540. PubMed ID: 32215058
[TBL] [Abstract][Full Text] [Related]
14. Primary prevention of venous thromboembolism in ambulatory cancer patients: recent advances and practical implications.
Harrigan AM; Carrier M; Wang TF
Pol Arch Intern Med; 2024 Apr; ():. PubMed ID: 38661514
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta-analysis.
Costa TA; Felix N; Costa BA; Godoi A; Nogueira A; Rossi A
Br J Haematol; 2023 Nov; 203(3):395-403. PubMed ID: 37533165
[TBL] [Abstract][Full Text] [Related]
16. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
Muñoz Martín AJ; Ortega I; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Rupérez A; Souto JC; Martín M; Salas E; Soria JM
Br J Cancer; 2018 Apr; 118(8):1056-1061. PubMed ID: 29588512
[TBL] [Abstract][Full Text] [Related]
17. [Venous thromboembolism: risk factors and prophylaxis].
Paffenholz P
Aktuelle Urol; 2024 Feb; 55(1):44-49. PubMed ID: 37339669
[TBL] [Abstract][Full Text] [Related]
18. Primary thromboprophylaxis in cancer outpatients - real-world evidence.
Liz-Pimenta J; Tavares V; Gramaça J; Rato J; Menezes M; Baleiras M; Guedes H; Reis J; Guedes C; Gomes R; Barbosa M; Sousa M; Khorana AA; Medeiros R
J Thromb Thrombolysis; 2024 Apr; ():. PubMed ID: 38643312
[TBL] [Abstract][Full Text] [Related]
19. Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO).
Kirschner M; do Ó Hartmann N; Parmentier S; Hart C; Henze L; Bisping G; Griesshammer M; Langer F; Pabinger-Fasching I; Matzdorff A; Riess H; Koschmieder S
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200741
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice.
Elalamy I; Cohen-Solal A; Hanon O; Mirabel M; Mismetti P; Spano JP
Curr Res Transl Med; 2023; 71(3):103405. PubMed ID: 37478777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
